Colony Group LLC Reviva Pharmaceuticals Holdings, Inc. Call Options Transaction History
Colony Group LLC
- $6.66 Billion
- Q3 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RVPH
# of Institutions
32Shares Held
5.55MCall Options Held
350KPut Options Held
97.8K-
Woodline Partners LP San Francisco, CA1.06MShares$1.14 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA1MShares$1.08 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny855KShares$922,9640.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY827KShares$892,7280.02% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT504KShares$544,1620.26% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $22.1M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...